Medtronic and Johnson & Johnson remain the world’s largest medical device companies. But after that, the roster is radically shifting amid a slew of mergers and acquisitions. In some cases such as GE, Philips and Siemens, major multinationals are breaking apart. We’ve sifted through data from public companies’ annual reports and other publicly disclosed information, […]
Fresenius extends deadline for $2B NxStage buyout, tops Q2 earnings forecast
Fresenius (NYSE:FMS) said today that it’s extending the deadline to close the $2 billion buyout of NxStage Medical (NSDQ:NXTM) by 90 days and posted second-quarter earnings that beat the consensus forecast. The German dialysis giant said it moved the merger deadline from August 7 to Nov. 5, but still expects to close the deal this year. […]
Fresenius put $2m into Vectorious Medical’s $10m Series B
Fresenius (NYSE:FMS) said today that its venture arm put $2 million into a Series B round for Vectorious Medical Technologies that brought in a total of nearly $10 million for the cardiac implant company. Tel Aviv-based Vectorius is developing the V-Lap implantable wireless heart monitor, which is designed to monitor pressure in the heart’s left atrium. The $9.5 […]
Fresenius Medical Care offers $585m in notes
Fresenius Medical Care (NYSE:FMS; ETR:FRE) this week successfully placed notes with an aggregate principal amount of €500 million ($584.9 million). The notes will mature in 7 years and have an annual coupon of 1.5%, the company noted. Fresenius reported that the issue price is 99.704% and the resulting yield amounts to 1.545%. “The transaction was very well […]
Fresenius closes $2B sale of Sound Inpatient Physicians
Fresenius Medical Care (NYSE:FMS; ETR:FRE) said late last week it closed its divestiture of its Sound Inpatient Physician Holdings to an investment consortium led by Summit Partners for approximately $2.2 billion (EU €1.9 billion). Bad Homburg vor der Höhe, Germany-based Fresenius said that the divestiture is part of the company’s overall goal of “sharpening the profile […]
Fresenius Medical Care, Humacyte ink $150m strategic partnership deal
Fresenius Medical Care (NYSE:FMS; ETR:FRE) said today it inked a $150 million strategic partnership deal with Humacyte through which Fresenius will gain exclusive rights to commercialize Humacyte’s Humacyl bioengineered blood vessel technology. Research Triangle Park, N.C.-based Humacyte is exploring the use of its Humacyl human acellular vessel as a conduit for hemodialysis in patients with end-stage renal […]
Medtronic taps former JP Morgan analyst Weinstein for strategy SVP | Personnel Moves – May 7, 2018
Medtronic (NYSE:MDT) said today it tapped former J.P. Morgan Chase & Co. analyst Mike Weinstein as its strategy senior VP. Prior to joining Medtronic, Weinstein served as a managing director for JP Morgan’s equity research healthcare team, holding positions within the unit for more than 20 years, the Fridley, Minn.-based company said. “We are excited to […]
Fresenius shares dip on Q1 EPS, sales miss
Shares in Fresenius Medical Care (NYSE:FMS; ETR:FRE) have fallen slightly today after the dialysis-focused medical group missed expectations on Wall Street and saw sales and profits shrink in their first quarter earnings report. The Bad Homburg vor der Höhe, Germany-based company posted profits of $292.3 million, or $1.09 per share, on sales of $4.8 billion for […]
Fresenius fires back at Akorn with counterclaims following failed merger
Fresenius (ETR:FRE) filed counterclaims against generic drugmaker Akorn Inc. (NSDQ:AKRX) this week in Delaware Chancery Court, alleging that Akorn tried to defraud the FDA with falsified testing data. Akorn filed suit against Fresenius one day after the company walked away from a $4.75 billion deal to acquire Akorn. Fresenius cited an investigation that found material breaches of FDA data […]
Fresenius to deal majority investment in Sound Inpatient Physicians to PE consortium for $2.2B
Fresenius Medical Care (NYSE:FMS; ETR:FRE) said last Saturday it inked a deal to divest itself of its controlling interest in Sound Inpatient Physician Holdings in a deal worth approximately $2.2 billion (EU €1.8 billion). The company said it is divesting its holdings in Sound to a consortium led by Summit Partners, and that it expects to generate […]
Fresenius abandons $4.3B Akorn merger, citing data integrity probe
Fresenius (ETR:FRE) is walking away from a $4.3 billion merger with U.S. generic drugmaker, Akorn Inc. (NSDQ:AKRX), citing an investigation that found material breaches of FDA data integrity requirements relating to Akorn’s operations. Fresenius said in a statement that it offered to delay its decision to give Akorn time to compete its own investigation, but Akorn turned […]
- 1
- 2
- 3
- …
- 11
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+